| Literature DB >> 28719665 |
Walelegn Worku Yallew1, Abera Kumie2, Feleke Moges Yehuala3.
Abstract
BACKGROUND: Hospital-acquired infection affects hundreds of millions of people worldwide. It is a major global issue for patient safety. Understanding the potential risk factors is important to appreciate the local context. A matched case control study design, which is the first of its kind in the study region, was undertaken to identify risk factors in teaching hospitals of Amhara regional state, Ethiopia.Entities:
Mesh:
Year: 2017 PMID: 28719665 PMCID: PMC5515417 DOI: 10.1371/journal.pone.0181145
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Background characteristics of cases and controls, in teaching hospitals in Amhara region, Ethiopia, 2015.
| Characteristics | Cases | Controls | P-Value | |
|---|---|---|---|---|
| 45(41.3%) | 238(54.6%) | 0.001 | ||
| No | 64(58.7%) | 198(45.4%) | ||
| Male | 64(58.7%) | 201((46.1%) | 0.01 | |
| Female | 45(41.2%) | 235(53.9%) | ||
| < = 1 year | 9(8.2%) | 24(5.5%) | ||
| 1–14 year | 14(12.84%) | 76(17.43%) | ||
| 15–35 years | 59(54.13% | 255(51.6% | 0.999 | |
| 36–55 years | 22(20.18%) | 90(20.64%) | ||
| > = 56 years | 5(4.6%) | 21(4.8%) | ||
| Medicine | 21(19.3%) | 118(27.1%) | ||
| pediatrics | 19(17.4% | 79(18.1%) | ||
| surgery | 53(48.6%) | 141(32.3%) | ||
| Gynecology | 16(14.7%) | 93(21.3%) | ||
| Ophthalmology | 0(0%) | 5(1.1%) | ||
| Yes | 67(61.5%) | 302(69.3%) | 0.003 | |
| No | 42(38.5%) | 134(30.7%) | ||
| Yes | 102(93.6%) | 431(98.9%) | 0.04 | |
| No | 7(6.4%) | 5(1.1%) | ||
| Yes | 3(2.8%) | 9 (2.1%) | ||
| No | 102 (93.6%) | 402 (92.2%) | 0.400 | |
| Unknown | 4(3.7%) | 25(5.7%) | ||
| Yes | 31(28.4%) | 92(21.1%) | 0.018 | |
| No | 55(50.5%) | 279 (64.0%) | ||
| Unknown | 23(21.1%) | 65(14.9%) | ||
| Non-Fatal diseases | 47 (43.1%) | 235 (53.9%) | 0.006 | |
| Ultimately fatal diseases | 39 (35.8%) | 141 (32.3%) | ||
| Rapidly fatal diseases | 13 (11.9%) | 38 (8.7%) | ||
| Unknown | 10 (9.2%) | 22 (5.0%) | ||
| Normally health patient | 32 (29.4%) | 146 (33.5%) | 0.494 | |
| Patient with mild systemic diseases | 27 (24.8%) | 85 (19.5%) | ||
| Patient with severe systemic disease that is not incapacitating | 32 (29.4%) | 100 (22.9%) | ||
| Patient with incapacitating systemic diseases that is a constant threat to life | 14 (12.8%) | 65 (14.9%) | ||
| Unknown | 4 (3.7%) | 40 (9.2%) | 0.021 | |
| Yes | 5 (4.6%) | 4 (0.9%) | ||
| No | 104 (95.4%) | 432(99.1%) | ||
| Yes | 83 (76.1%) | 291(66.7%) | 0.05 | |
| No | 26 (23.9%) | 145(33.3%) | ||
| Yes | 33 (30.3%) | 75 (17.2%) | 0.003 | |
| No | 76 (69.7%) | 361(82.8%) | ||
| Yes | 18 (16.5%) | 29 (6.7%) | ||
| No | 91 (83.5%) | 407(93.3%) | 0.001 | |
| Yes | 64 (58.7%) | 146(33.5%) | 0.000 | |
| No | 45 (41.3%) | 290(66.5%) | ||
| <8 days (below the median | 63 (57.8%) | 209(47.9%) | 0.06 | |
| > = 8 days (above or equal to median) | 46 (42.2%) | 227(52.1%) | ||
| Yes | 104 (95.4%) | 294(67.4%) | 0.000 | |
| No | 5 (4.6%) | 142(32.6%) | ||
Risk factors for HAI in teaching hospitals in Amhara region, Ethiopia 2015.
| Characteristics | Cases | Controls | Crude OR (Odds Ratio) | Adjusted OR (Odds Ratio) | |
|---|---|---|---|---|---|
| Yes | 45(41.3%) | 238(54.6%) | 0.38(0. 21–0.68) | 0.81(0.35–1.86) | |
| No | 64(58.7%) | 198(45.4%) | 1 | 1 | |
| Yes | 102(93.6%) | 431(98.9%) | 0.12(0.003-.03) | 0.18(0.03–0.97) | |
| No | 7(6.4%) | 5(1.1%) | 1 | 1 | |
| Male | 64(58.7%) | 201((46.1%) | 1 | 1 | |
| Female | 45(41.2%) | 235(53.9%) | 0.57(0.37–0.89) | 0.65(0.37–1.13) | |
| No | 55(50.5%) | 279(64.0%) | 1 | 1 | |
| Yes | 31(28.4%) | 92(21.1%) | 1. 78(1.03–3.04) | 2.34(1.17–4.69) | |
| Unknown | 23(21.1%) | 65(14.9%) | 1.86(1.03–3.37) | 1.26(0.61–2.59)) | |
| Non-Fatal diseases | 47 (43.1%) | 235(53.9%) | 1 | 1 | |
| Ultimately fatal diseases | 39 (35.8%) | 141(32.3%) | 1.48(0.88–2.48) | 1.34(0.63–2.85)) | |
| Rapidly fatal diseases | 13 (11.9%) | 38 (8.7%) | 1.76(0.86–3.60) | 2.51(0.84–7.44)) | |
| Unknown | 10 (9.2%) | 22 (5.0%) | 2.54(1.05–6.13) | 1.04(0.30–3.58)) | |
| Normally health patient | 32 (29.4%) | 146(33.5%) | 1 | 1 | |
| Patient with mild systemic diseases | 27 (24.8%) | 85 (19.5%) | 1.68(0.91–3.13) | 0.78(0.36–1.72) | |
| Patient with severe systemic disease that is not incapacitating | 32 (29.4%) | 100(22.9%) | 1.84(0.98–3.47) | 1.08(0.41–2.87) | |
| Patient with incapacitating systemic diseases that is a constant threat to life | 14 (12.8%) | 65 (14.9%) | 1.20(0.55–2.59) | 1.19(0.35–4.11) | |
| Unknown | 4 (3.7%) | 40 (9.2%) | 0.28(0.07–1.03) | 0.09(0.01–0.64) | |
| Yes | 5 (4.6%) | 4 (0.9%) | 5.00(1.34–18.61) | 6.92(1.28–37.47) | |
| No | 104(95.4%) | 432(99.1%) | 1 | 1 | |
| Yes | 83 (76.1%) | 291(66.7%) | 1.61(0.99–2.63) | 1.17(0.59–2.32) | |
| No | 26 (23.9%) | 145(33.3%) | 1 | 1 | |
| Yes | 33 (30.3%) | 75 (17.2%) | 2.30(1.37–3.87) | 1.23(0.59–2.55) | |
| No | 76 (69.7%) | 361(82.8%) | 1 | 1 | |
| Yes | 18 (16.5%) | 29 (6.7%) | 3.40(1.66–6.97) | 0.80(0.28–2.31) | |
| No | 91 (83.5%) | 407(93.3%) | 1 | 1 | |
| Yes | 64 (58.7%) | 146(33.5%) | 3.31(2.05–5.36) | 2.35(1.08–5.09) | |
| No | 45 (41.3%) | 290(66.5%) | 1 | 1 | |
| Yes | 104(95.4%) | 294(67.4%) | 10.69(4.22–27.07) | 8.63(3.11–23.95) | |
| No | 5 (4.6%) | 142(32.6%) | 1 | 1 | |
* Statistically significant association P<0.05
**strong statistically significant p between 0.001 & 0.05
*** Very strong, statistically significant P<0.001.